A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Principal Investigator Last Name
Awardee Organization
Awardee State
Contact PI Country
Project Detail
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official